POS0907 EFFECT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND INADEQUATE RESPONSE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS

MLA

I.B. McInnes, et al. “Pos0907 Effect of Upadacitinib on Reducing Pain in Patients with Active Ankylosing Spondylitis and Inadequate Response to Nonsteroidal Anti-Inflammatory Drugs.” Annals of the Rheumatic Diseases, vol. 80, May 2021, pp. 712–13. EBSCOhost, https://doi.org/10.1136/annrheumdis-2021-eular.604.

APA

I.B. McInnes, R. Lippe, K. de Vlam, A. Ostor, A. Deodhar, Xenofon Baraliakos, A. Maniccia, T. Gao, I. H. Song, Louis Bessette, & C. Saffore. (2021). Pos0907 Effect of Upadacitinib on Reducing Pain in Patients with Active Ankylosing Spondylitis and Inadequate Response to Nonsteroidal Anti-Inflammatory Drugs. Annals of the Rheumatic Diseases, 80, 712–713. https://doi.org/10.1136/annrheumdis-2021-eular.604

Chicago

I.B. McInnes, R. Lippe, K. de Vlam, A. Ostor, A. Deodhar, Xenofon Baraliakos, A. Maniccia, et al. 2021. “Pos0907 Effect of Upadacitinib on Reducing Pain in Patients with Active Ankylosing Spondylitis and Inadequate Response to Nonsteroidal Anti-Inflammatory Drugs.” Annals of the Rheumatic Diseases 80 (May): 712–13. doi:10.1136/annrheumdis-2021-eular.604.